Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214227 · ClinicalTrials.gov registry record
ATM Variants in Radiotherapy Patients
A clinical trial of Radiotherapy, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT00214227: Completed study of Radiotherapy, sponsored by University of Wisconsin, Madison.
NCT00214227 is a study of Radiotherapy that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants, below the 88-participant average among 4 other Radiotherapy trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00214227, a study of Radiotherapy, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the baseline incidence of variant alleles in the ATM and/or other DNA repair genes present in the Native American population versus the non-Native American population. It is thought that a higher baseline incidence of the variant alleles in the ATM gene may correlate to higher rates and higher grades of radiation toxicities noted in the Native American population.
Primary Outcome
to determine the baseline incidence of variant alleles in ATM resent in the population of Native americans with cancer who are undergoing radiation therapy to a similar group of non-native americans who have undergone or are undergoing raditohterapy
Conditions Studied
Study Locations (1)
Wisconsin
- University of Wisconsin Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-01 |
What the finished NCT00214227 record still lists
NCT00214227 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 88-participant average among 4 other Radiotherapy trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Radiotherapy appearing as the primary indexed condition, and to 0 interventions.
NCT00214227 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00214227 about?
NCT00214227 is a clinical study titled "ATM Variants in Radiotherapy Patients". The purpose of this study is to compare the baseline incidence of variant alleles in the ATM and/or other DNA repair genes present in the Native American population versus the non-Native American population. It is thought that a higher baseline incidence of the variant alleles in the ATM gene may co...
What is the current status of trial NCT00214227?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-12. Estimated completion is 2013-01.
What conditions does trial NCT00214227 study?
This clinical trial studies the following conditions: Radiotherapy.
Who is sponsoring clinical trial NCT00214227?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00214227 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiotherapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
RECRUITING · Phase 2
-
Serial MRI Scans During Radiation Therapy
RECRUITING · NA
-
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
ACTIVE NOT RECRUITING · Phase 1
-
T2* MRI Analysis for Sarcoma
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia